Abstract:High expression of S-phase kinase associated protein 2 (Skp2) is associated with numerous clinicopathological parameters, including histology, lymph node metastasis, smoking status, differentiation and Tumor-Node-Metastasis stage in non-small cell lung cancer (NSCLC). Skp2 protein is overexpressed in lung squamous cell carcinoma (LUSC), compared with lung adenocarcinoma (LUAD), whilst the clinicopathological and prognostic implications in LUAD or LUSC remain unclear. A larger study is required to assess the differences in Skp2 expression between these NSCLC types. In the present study, the clinicopathological features and immunohistochemical expression of the Skp2 protein were studied in 500 patients with NSCLC (351 with LUAD and 149 with LUSC). Survival analyses were performed using Kaplan-Meier method and Cox regression model. Skp2 associated genes were identified based on the data from The Cancer Genome Atlas database. Skp2 was overexpressed in patients with LUSC, compared with LUAD (P<0.001). In histology subgroup analysis, differences in Skp2 protein expression were observed in patients with LUAD, based on sex, differentiation, smoking history, stage, lymph node metastasis and tumor diameter (P<0.05), but not in patients with LUSC except for smoking status. High Skp2 protein expression in patients with LUAD was associated with reduced overall survival (OS; P<0.001), but not in patients with LUSC (P=0.686). The multivariate analysis demonstrated that Skp2 expression is an independent unfavorable prognostic factor for OS in patients with LUAD (RR=1.845, P<0.05). Bioinformatics analyses revealed that minichromosome maintenance complex component 2, cell division cycle 45, replication factor C subunit 4, which are differently expressed in LUAD and LUSC, are associated with Skp2 expression and participate in DNA replication and G1/S transition. Skp2 protein expression differs in LUAD and LUSC. The clinicopathological and prognostic implications based on Skp2 expression in LUAD and LUSC should be considered different. LUSC with high Skp2 expression may have robust proliferation ability.

Effects of Skp2 on the Biologic Properties of Tumors and Its Use As a Prognostic Marker and a Theraputic Target

Cytoplasmic Skp2 Expression Is Increased In Human Melanoma And Correlated With Patient Survival

The Skp2 Pathway: A Critical Target for Cancer Therapy

Identification of Spindle and Kinetochore-Associated Family Genes As Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment

Skp2 Modulates Proliferation, Senescence and Tumorigenesis of Glioma

Skp2: A critical molecule for ubiquitination and its role in cancer

SKP2 Targeted Inhibition Suppresses Human Uveal Melanoma Progression by Blocking Ubiquitylation of P27.

SKP2 Promotes Breast Cancer Tumorigenesis and Radiation Tolerance Through PDCD4 Ubiquitination.

Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review

Skp2-mediated Ubiquitination and Mitochondrial Localization of Akt Drive Tumor Growth and Chemoresistance to Cisplatin.

Skp2 Stabilizes Mcl-1 and Confers Radioresistance in Colorectal Cancer

Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer

SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies

High Skp2/Low P57kip2 Expression is Associated with Poor Prognosis in Human Breast Carcinoma

The Effects of Skp2-p27 (kip1) on the Proliferation and Metastasis in Gallbladder Carcinoma

Skp2 Expression Has Different Clinicopathological and Prognostic Implications in Lung Adenocarcinoma and Squamous Cell Carcinoma

Expression and Functional Role of S Phase Kinase Associated Protein 2 (skp2) in Development of Glioma

Skp2 Depletion Reduces Tumor-Initiating Properties and Promotes Apoptosis in Synovial Sarcoma

SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma.

High Skp2/Low p57 Expression is Associated with Poor Prognosis in Human Breast Carcinoma

Skp2–MacroH2A1–CDK8 Axis Orchestrates G2/M Transition and Tumorigenesis